These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27167393)

  • 1. Chemical probes: A shared toolbox.
    Scott AR
    Nature; 2016 May; 533(7602):S60-1. PubMed ID: 27167393
    [No Abstract]   [Full Text] [Related]  

  • 2. New class of sleep drugs may offer a safer night's rest.
    Willyard C
    Nat Med; 2012 Jul; 18(7):996. PubMed ID: 22772537
    [No Abstract]   [Full Text] [Related]  

  • 3. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
    Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
    Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer: Bet on drug resistance.
    Settleman J
    Nature; 2016 Jan; 529(7586):289-90. PubMed ID: 26735017
    [No Abstract]   [Full Text] [Related]  

  • 5. Patent-free pact pushes the boundaries of precompetitive research.
    Dolgin E
    Nat Med; 2014 Jun; 20(6):564-5. PubMed ID: 24901552
    [No Abstract]   [Full Text] [Related]  

  • 6. First-in-class insomnia drug on the brink of approval nod.
    Osborne R
    Nat Rev Drug Discov; 2013 Jul; 12(7):492-3. PubMed ID: 23812257
    [No Abstract]   [Full Text] [Related]  

  • 7. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 8. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma.
    Lee S; Rellinger EJ; Kim KW; Craig BT; Romain CV; Qiao J; Chung DH
    Surgery; 2015 Sep; 158(3):819-26. PubMed ID: 26067464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure.
    Qi J
    Cold Spring Harb Perspect Biol; 2014 Dec; 6(12):a018663. PubMed ID: 25452384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential effects of increased openness in pharma: the original knowledge behind new drugs.
    Bignami F; Mattsson P
    Drug Discov Today; 2019 Oct; 24(10):1957-1962. PubMed ID: 31254489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedicine. Pharma firms push for sharing of cancer trial data.
    Bhattacharjee Y
    Science; 2012 Oct; 338(6103):29. PubMed ID: 23042862
    [No Abstract]   [Full Text] [Related]  

  • 13. Suvorexant: something new for sleep?
    Reddy A; Puvvada SC; Kommisetti S; El-Mallakh RS; Lippmann S
    Acta Neuropsychiatr; 2015 Feb; 27(1):53-5. PubMed ID: 25397996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open innovation.
    Hodson R
    Nature; 2016 May; 533(7602):S53. PubMed ID: 27167389
    [No Abstract]   [Full Text] [Related]  

  • 15. HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist.
    Devaraj SG; Fiskus W; Shah B; Qi J; Sun B; Iyer SP; Sharma S; Bradner JE; Bhalla KN
    Leukemia; 2016 Feb; 30(2):504-8. PubMed ID: 26148704
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of patent sharing in neglected disease drug discovery.
    Edlin C
    Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of suvorexant.
    Stahl SM
    CNS Spectr; 2016 Jun; 21(3):215-8. PubMed ID: 27322687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to patient-level trial data--a boon to drug developers.
    Eichler HG; Pétavy F; Pignatti F; Rasi G
    N Engl J Med; 2013 Oct; 369(17):1577-9. PubMed ID: 24144395
    [No Abstract]   [Full Text] [Related]  

  • 19. Suvorexant (Belsomra) for insomnia.
    Med Lett Drugs Ther; 2015 Mar; 57(1463):29-31. PubMed ID: 25719996
    [No Abstract]   [Full Text] [Related]  

  • 20. [Synthesis and pharmacologic properties of s-triazolo-1,4-diazepine derivatives].
    Guryn R; Szadowska A; Kiełek MB
    Acta Pol Pharm; 1988; 45(6):512-6. PubMed ID: 3254673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.